Journal of Current Medical Research and Opinion https://cmro.in/index.php/jcmro <p data-start="240" data-end="661">The <em data-start="244" data-end="301">Journal of Current Medical Research and Opinion (JCMRO)</em> is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research in the field of medical and health sciences. The journal aims to promote the dissemination of scientifically sound and clinically relevant knowledge that contributes to the advancement of healthcare, biomedical research, and evidence-based medical practice.</p> <p data-start="663" data-end="1037">JCMRO provides a platform for researchers, clinicians, and academicians to share innovative findings, critical analyses, and emerging perspectives across a wide range of medical disciplines. The journal adheres to internationally recognized standards of publication ethics, following the guidelines of COPE and ICMJE, and ensures a rigorous double-blind peer review process.</p> <h1 data-section-id="1jm1vl" data-start="1044" data-end="1071"><span role="text"><strong data-start="1049" data-end="1071">Aim of the Journal</strong></span></h1> <p data-start="1073" data-end="1104">The primary aim of JCMRO is to:</p> <ul data-start="1105" data-end="1411"> <li data-section-id="1jvqtjf" data-start="1105" data-end="1195"> <p data-start="1107" data-end="1195">Publish original and impactful research that advances clinical and biomedical sciences</p> </li> <li data-section-id="tb3j1c" data-start="1196" data-end="1270"> <p data-start="1198" data-end="1270">Support evidence-based medical practice and healthcare decision-making</p> </li> <li data-section-id="1pr7drq" data-start="1271" data-end="1338"> <p data-start="1273" data-end="1338">Encourage interdisciplinary research and innovation in medicine</p> </li> <li data-section-id="1wcrfq0" data-start="1339" data-end="1411"> <p data-start="1341" data-end="1411">Provide a global platform for researchers, clinicians, and educators</p> </li> </ul> <p> </p> <h1 data-section-id="ee3n0s" data-start="1418" data-end="1447"><span role="text"><strong data-start="1423" data-end="1447">Scope of the Journal</strong></span></h1> <p data-start="1449" data-end="1522">JCMRO welcomes submissions from, but not limited to, the following areas:</p> <h3 data-section-id="11hwvtj" data-start="1524" data-end="1552"><span role="text"><strong data-start="1531" data-end="1552">Clinical Sciences</strong></span></h3> <ul data-start="1553" data-end="1687"> <li data-section-id="1hw3y97" data-start="1553" data-end="1574"> <p data-start="1555" data-end="1574">Internal Medicine</p> </li> <li data-section-id="5ajhj" data-start="1575" data-end="1589"> <p data-start="1577" data-end="1589">Cardiology</p> </li> <li data-section-id="1kzggja" data-start="1590" data-end="1603"> <p data-start="1592" data-end="1603">Neurology</p> </li> <li data-section-id="9obxko" data-start="1604" data-end="1616"> <p data-start="1606" data-end="1616">Oncology</p> </li> <li data-section-id="1nvgbsc" data-start="1617" data-end="1634"> <p data-start="1619" data-end="1634">Endocrinology</p> </li> <li data-section-id="1uwc6vi" data-start="1635" data-end="1655"> <p data-start="1637" data-end="1655">Gastroenterology</p> </li> <li data-section-id="zunodb" data-start="1656" data-end="1671"> <p data-start="1658" data-end="1671">Pulmonology</p> </li> <li data-section-id="1s0abip" data-start="1672" data-end="1687"> <p data-start="1674" data-end="1687">Dermatology</p> </li> </ul> <h3 data-section-id="1ql3tau" data-start="1689" data-end="1738"><span role="text"><strong data-start="1696" data-end="1738">Biomedical and Pharmaceutical Sciences</strong></span></h3> <ul data-start="1739" data-end="1890"> <li data-section-id="v4uh2m" data-start="1739" data-end="1770"> <p data-start="1741" data-end="1770">Pharmacology and Toxicology</p> </li> <li data-section-id="dptxlm" data-start="1771" data-end="1792"> <p data-start="1773" data-end="1792">Clinical Pharmacy</p> </li> <li data-section-id="rqzm6g" data-start="1793" data-end="1826"> <p data-start="1795" data-end="1826">Drug Development and Delivery</p> </li> <li data-section-id="d8d44a" data-start="1827" data-end="1866"> <p data-start="1829" data-end="1866">Biotechnology and Molecular Biology</p> </li> <li data-section-id="hbign6" data-start="1867" data-end="1890"> <p data-start="1869" data-end="1890">Medicinal Chemistry</p> </li> </ul> <h3 data-section-id="10koavr" data-start="1892" data-end="1943"><span role="text"><strong data-start="1899" data-end="1943">Public Health and Allied Health Sciences</strong></span></h3> <ul data-start="1944" data-end="2058"> <li data-section-id="1rpui3n" data-start="1944" data-end="1960"> <p data-start="1946" data-end="1960">Epidemiology</p> </li> <li data-section-id="jujnq7" data-start="1961" data-end="1983"> <p data-start="1963" data-end="1983">Community Medicine</p> </li> <li data-section-id="1oh4j4o" data-start="1984" data-end="2007"> <p data-start="1986" data-end="2007">Preventive Medicine</p> </li> <li data-section-id="1psaem7" data-start="2008" data-end="2025"> <p data-start="2010" data-end="2025">Global Health</p> </li> <li data-section-id="nwujyk" data-start="2026" data-end="2058"> <p data-start="2028" data-end="2058">Health Policy and Management</p> </li> </ul> <h3 data-section-id="1ye0m26" data-start="2060" data-end="2107"><span role="text"><strong data-start="2067" data-end="2107">Emerging and Interdisciplinary Areas</strong></span></h3> <ul data-start="2108" data-end="2275"> <li data-section-id="30e8dm" data-start="2108" data-end="2134"> <p data-start="2110" data-end="2134">Translational Medicine</p> </li> <li data-section-id="rvxysj" data-start="2135" data-end="2162"> <p data-start="2137" data-end="2162">Evidence-Based Medicine</p> </li> <li data-section-id="a9eybm" data-start="2163" data-end="2197"> <p data-start="2165" data-end="2197">Medical Education and Training</p> </li> <li data-section-id="ra0srd" data-start="2198" data-end="2233"> <p data-start="2200" data-end="2233">Digital Health and Telemedicine</p> </li> <li data-section-id="1smjdat" data-start="2234" data-end="2275"> <p data-start="2236" data-end="2275">Artificial Intelligence in Healthcare</p> </li> </ul> <h1 data-section-id="1ll39le" data-start="2282" data-end="2318"> </h1> <h1 data-section-id="1ll39le" data-start="2282" data-end="2318"><span role="text"><strong data-start="2287" data-end="2318">Types of Articles Published</strong></span></h1> <ul data-start="2319" data-end="2489"> <li data-section-id="1peju2n" data-start="2319" data-end="2349"> <p data-start="2321" data-end="2349">Original Research Articles</p> </li> <li data-section-id="12oswn9" data-start="2350" data-end="2369"> <p data-start="2352" data-end="2369">Review Articles</p> </li> <li data-section-id="1bulq9q" data-start="2370" data-end="2410"> <p data-start="2372" data-end="2410">Systematic Reviews and Meta-Analyses</p> </li> <li data-section-id="1n4cyed" data-start="2411" data-end="2443"> <p data-start="2413" data-end="2443">Case Reports and Case Series</p> </li> <li data-section-id="1tue089" data-start="2444" data-end="2468"> <p data-start="2446" data-end="2468">Short Communications</p> </li> <li data-section-id="ririm" data-start="2469" data-end="2489"> <p data-start="2471" data-end="2489">Clinical Studies</p> </li> </ul> <p data-start="2544" data-end="2795"> </p> en-US editor@cmro.in (Edwin Jarald) daga@cmro.in (Gaurav Daga) Mon, 01 Jun 2026 00:00:00 +0000 OJS 3.3.0.15 http://blogs.law.harvard.edu/tech/rss 60 Prevalence of Toxoplasma gondii During Pregnancy and the Function of the IL6-174 G>C Mutation https://cmro.in/index.php/jcmro/article/view/1186 <p><em>Toxoplasma gondii</em> is an intracellular parasite that leads to congenital toxoplasmosis and to neuro-ocular sequelae in newborns, some of which are severe, stillbirth and miscarriage. Polymorphisms in cytokine genes is one factor of the host genome that might be involved in the susceptibility to infection during prenatal period. In this study, the susceptibility of pregnant women to <em>Toxoplasma gondii</em> infection was investigated in relation to IL6 174 G&gt;C (rs1800795) polymorphism.</p> <p><strong>Methods:</strong> The Women's and Children's Hospital in Babylon, Iraq, undertook a case control study from November 2024 to February 2024. Fifty pregnant women were included in the study; 20 of them were cases with proven <em>T. gondii</em> infection (anti IgG positive) and 30 were healthy controls who tested negative for the parasite. Allele Specific PCR for the IL6 174 G&gt;C polymorphism was used for genotyping. A computerised VIDAS Toxo IgG II (ELFA) developed by bioMérieux in France was used to screen the sera for anti-<em>T. gondii</em> IgG antibodies. Logistic regression was used for estimation of odds ratio (OR) under the codominant, dominant and recessive genetic model, and Fisher's exact test was used to compare the frequencies of geno/alleles.</p> <p><strong>Results:</strong> In the cases, the GC heterozygote was significantly more common (50%) than in the controls (16.7%). There was a significant in the overall genotype distribution between the two groups (Fisher's exact test; P = 0.041). Under the codominant model, with GG as the reference, logistic regression analysis showed association of the GC genotype with an increased risk of infection (OR = 5.667, 95% CI: 1.369–23.462, P = 0.017). The model with overdominant high risk for heterozygotes (GC vs. GG+CC) was confirmed with strong and statistically significant increased risk (OR = 5.000, 95% CI: 1.363–18.348, P = 0.015). There was no significant found between the CC homozygote (OR = 1.417, P = 0.653). The control group was not in Hardy Weinberg equilibrium (χ² = 12.05, df = 1, P &lt; 0.001), which was due to the small sample size.</p> <p><strong>Conclusion:</strong> The IL6 174 G&gt;C polymorphism and specially the heterozygote GC is more susceptible to the <em>Toxoplasma gondii</em> during pregnancy. This could be due to an over-dominant effect, in which one copy of the C allele changes the regulation of interleukin 6, which could upset the Th1/Th2 balance that is necessary for parasite control and foetal immune tolerance. Prior to clinical translation, bigger multicenter prospective trials with direct measurement of blood IL 6 levels are necessary to assess the polymorphism's potential as a genetic marker for risk stratification in prenatal treatment.</p> Mohammed Talib AL-Tameemi Copyright (c) 2026 https://creativecommons.org/licenses/by/4.0 https://cmro.in/index.php/jcmro/article/view/1186 Sat, 13 Jun 2026 00:00:00 +0000